Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Watarai, Shinobu ^a   Iwase, Tana ^a   Tajima, Tomoko ^a   Yuba, Eiji ^a   Kono, Kenji ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; INTERLEUKIN 4; LIPOSOME; OVALBUMIN; SUCCINYLATED POLY(GLYCIDOL); UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; POLYGLYCIDOL; PROPANEDIOL DERIVATIVE; SUCCINIC ACID DERIVATIVE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTE; MOUSE; NONHUMAN; PH; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; SPLEEN; TH1 CELL; TH2 CELL;

ANIMALS; DRUG CARRIERS; FEMALE; HYDROGEN-ION CONCENTRATION; IMMUNIZATION; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; INTERFERON-GAMMA; INTERLEUKIN-4; LIPOSOMES; MICE; MICE, INBRED BALB C; OVALBUMIN; PROPYLENE GLYCOLS; SPLEEN; SUCCINATES; TH1 CELLS; TH2 CELLS; VACCINES;

EID: 84874511612     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/903234     Document Type: Article

References (39)

1. + T lymphocytes. T Lymphocyte Subpopulation in Immunotoxicology 1998 Chichester, UK John Wiley & Sons 7 32
2. Mosmann T. R., Sad S., The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 1996 17 3 138 146 2-s2.0-0029928417 10.1016/0167-5699(96)80606-2 (Pubitemid 26074503)
3. Gregoriadis G., Immunological adjuvants: a role for liposomes. Immunology Today 1990 11 3 89 97 2-s2.0-0025129271 (Pubitemid 20062716)
4. Romero E. L., Morilla M. J., Topical and mucosal liposomes for vaccine delivery. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2011 3 4 356 375 2-s2.0-79958258351 10.1002/wnan.131
5. Gregory R. L., Michalek S. M., Richardson G., Harmon C., Hilton T., McGhee J. R., Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes. Infection and Immunity 1986 54 3 780 786 2-s2.0-0022979665 (Pubitemid 17186450)
6. Kahl L. P., Lelchuk R., Scott C. A., Beesley J., Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis. Infection and Immunity 1990 58 10 3233 3241 2-s2.0-0025082940 (Pubitemid 20293430)
7. Bülow R., Boothroyd J. C., Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. Journal of Immunology 1991 147 10 3496 3500 2-s2.0-0025787983
8. Li W., Watarai S., Iwasaki T., Kodama H., Suppression of Salmonella enterica serovar Enteritidis excretion by intraocular vaccination with fimbriae proteins incorporated in liposomes. Developmental and Comparative Immunology 2004 28 1 29 38 2-s2.0-0041328966 10.1016/S0145-305X(03)00086-7 (Pubitemid 37083236)
9. Irie T., Watarai S., Iwasaki T., Kodama H., Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes. Fish and Shellfish Immunology 2005 18 3 235 242 2-s2.0-7044224732 10.1016/j.fsi.2004.07.006 (Pubitemid 39415883)
10. Rhalem A., Bourdieu C., Luffau G., Pery P., Vaccination of mice with liposome-entrapped adult antigens of Nippostrongylus brasiliensis. Annales de l'Institut Pasteur. Immunology 1988 139 2 157 166 2-s2.0-0023878172
11. O'Hagan D. T., Rappuoli R., Novel approaches to vaccine delivery. Pharmaceutical Research 2004 21 9 1519 1530 (Pubitemid 41184379)
12. Kersten G. F. A., Crommelin D. J. A., Liposomes and ISCOMs. Vaccine 2003 21 9-10 915 920 2-s2.0-0037435928 10.1016/S0264-410X(02)00540-6 (Pubitemid 36126426)
13. Gregoriadis G., Bacon A., Caparros-Wanderley W., McCormack B., A role for liposomes in genetic vaccination. Vaccine 2002 20 supplement 5 B1 B9 2-s2.0-0037146918 10.1016/S0264-410X(02)00514-5 (Pubitemid 35435390)
14. Christensen D., Korsholm K. S., Andersen P., Agger E. M., Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines 2011 10 4 513 521 2-s2.0-79955084313 10.1586/erv.11.17
15. Akagi T., Wang X., Uto T., Baba M., Akashi M., Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials 2007 28 23 3427 3436 2-s2.0-34248332505 10.1016/j.biomaterials.2007.04.023 (Pubitemid 46729729)
16. Yoshikawa T., Okada N., Oda A., Matsuo K., Matsuo K., Mukai Y., Yoshioka Y., Akagi T., Akashi M., Nakagawa S., Development of amphiphilic γ -PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier. Biochemical and Biophysical Research Communications 2008 366 2 408 413 2-s2.0-37449022610 10.1016/j.bbrc.2007.11.153 (Pubitemid 50010411)
17. Kwon Y. J., Standley S. M., Goh S. L., Fréchet J. M. J., Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. Journal of Controlled Release 2005 105 3 199 212 2-s2.0-21744448012 10.1016/j.jconrel.2005.02.027 (Pubitemid 40941986)
18. Kunisawa J., Nakanishi T., Takahashi I., Okudaira A., Tsutsumi Y., Katayama K., Nakagawa S., Kiyono H., Mayumi T., Sendai virus fusion protein-mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system. Journal of Immunology 2001 167 3 1406 1412 2-s2.0-0035421690 (Pubitemid 32703138)
19. Bungener L., Serre K., Bijl L., Leserman L., Wilschut J., Daemen T., Machy P., Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine 2002 20 17-18 2287 2295 2-s2.0-0037157276 10.1016/S0264-410X(02)00103-2 (Pubitemid 34497039)
20. Yuba E., Kojima C., Harada A., Tana, Watarai S., Kono K., pH-sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity. Biomaterials 2010 31 5 943 951 2-s2.0-70649102108 10.1016/j.biomaterials.2009.10.006
21. Sakaguchi N., Kojima C., Harada A., Kono K., Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH. Bioconjugate Chemistry 2008 19 5 1040 1048 2-s2.0-44349138168 10.1021/bc7004736 (Pubitemid 351748312)
22. Kono K., Zenitani K. I., Takagishi T., Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochimica et Biophysica Acta 1994 1193 1 1 9 2-s2.0-0027936349 10.1016/0005-2736(94)90325-5 (Pubitemid 24234171)
23. Watarai S., Kushi Y., Shigeto R., Misawa N., Eishi Y., Handa S., Yasuda T., Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N -glycolylneuraminic acid-containing gangliosides. Journal of Biochemistry 1995 117 5 1062 1069 2-s2.0-0029048934
24. Mark A., Björkstén B., Granström M., ImmunoglobulinEresponsesto diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine 1995 13 7 669 673
25. Aggerbeck H., Wantzin J., Heron I., Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations-III. Vaccine 1996 14 13 1265 1272 2-s2.0-0030250849 10.1016/S0264-410X(96)00092-8 (Pubitemid 26388740)
26. Nothdurft H. D., Jelinek T., Marschang A., Maiwald H., Kapaun A., Löscher T., Adverse reactions to Japanese encephalitis vaccine in travellers. Journal of Infection 1996 32 2 119 122 2-s2.0-0029937621 10.1016/S0163-4453(96)91281-5 (Pubitemid 26131692)
27. Doherty P. C., Kelso A., Toward a broadly protective influenza vaccine. Journal of Clinical Investigation 2008 118 10 3273 3275
28. McMichael A. J., Hanke T., HIV vaccines 1983-2003. Nature Medicine 2003 9 7 874 880 (Pubitemid 36889929)
29. Chen M., Sällberg M., Sönnerborg A., Weiland O., Mattsson L., Jin L., Birkett A., Peterson D., Milich D. R., Limited humoral immunity in hepatitis C virus infection. Gastroenterology 1999 116 1 135 143 (Pubitemid 29013502)
30. Yerly D., Heckerman D., Allen T. M., Chisholm J. V., Faircloth K., Linde C. H., Frahm N., Timm J., Pichler W. J., Cerny A., Brander C., Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance. Journal of Virology 2008 82 6 3147 3153 2-s2.0-40149099742 10.1128/JVI.02252-07 (Pubitemid 351329204)
31. Han M., Watarai S., Kobayashi K., Yasuda T., Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization. Journal of Veterinary Medical Science 1997 59 12 1109 1114 2-s2.0-0031307162 (Pubitemid 127539895)
32. Watarai S., Han M., Tana, Kodama H., Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes. Journal of Veterinary Medical Science 1998 60 9 1047 1050 2-s2.0-0032160671 (Pubitemid 128538054)
33. Snapper C. M., Mond J. J., Towards a comprehensive view of immunoglobulin class switching. Immunology Today 1993 14 1 15 17 2-s2.0-0027465755 (Pubitemid 23028245)
34. Casadevall A., Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infection and Immunity 2003 71 8 4225 4228 2-s2.0-0042766764 10.1128/IAI.71.8.4225-4228.2003 (Pubitemid 36919884)
35. Casadevall A., Pirofski L. A., A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Advances in Immunology 2006 91 1 44 2-s2.0-33747821468 10.1016/S0065-2776(06) 91001-3 (Pubitemid 44286993)
36. de Gregorio E., Tritto E., Rappuoli R., Alum adjuvanticity: unraveling a century old mystery. European Journal of Immunology 2008 38 8 2068 2071 2-s2.0-51149090409 10.1002/eji.200838648
37. Lindblad E. B., Aluminium compounds for use in vaccines. Immunology and Cell Biology 2004 82 5 497 505 (Pubitemid 39421059)
38. Harandi A. M., Medaglini D., Shattock R. J., Vaccine adjuvants: a priority for vaccine research. Vaccine 2010 28 12 2363 2366 2-s2.0-77249147827 10.1016/j.vaccine.2009.12.084
39. Hem S. L., White J. L., Structure and properties of aluminum-containing adjuvants. Pharmaceutical Biotechnology 1995 6 249 276